- HK$1.30bn
- HK$197.35m
- CNY823.51m
Brief: PW Medtech Group Reports FY Profit Attributable RMB106.0 Mln
Advisory: Alert inadvertently tagged to Medical Devices Venture withdrawn
Brief: Pw Medtech To Buy Medical Devices Molds And Components From Lepu Medical Group
Brief: Pw Medtech Group Says HY Profit Attributable falls 92.0%
Brief: Pw Medtech Group Ltd Sees HY Significant Decrease In Its Profit
Brief: PW Medtech Entered Into Sales Of Medical Devices Framework Agreement With Lepu Medical
Brief: Pw Medtech Posts For Year Profit Attributable Rmb739.1 Million, Increase Of 17.0%
Brief: Pw Medtech Group Gets Allocated 10.9 Mln Lepu Biopharma Shares At Final Offer Price Of HK$7.13 Each
Brief: PW Medtech Group Placed Order For Application To Subscribe For 10.9 Mln Lepu Biopharma Shares With Total Application Money Of About HK$81 Mln
Brief: PW Medtech Group Says Unit To Acquire 51.5% Stake In Beijing Ruijian High-Tech Biological Technology
Brief: Pw Medtech Announces Acquisition Of 51% Stake In Sichuan Ruijian Medical Technology Co
Brief: PW Medtech Group Posts HY Profit Attributable RMB 761.1 MLN
Brief: PW Medtech Says Unit To Lend Rmb180 Mln To Beijing Tianxia Pule Medical Investment
Brief: PW Medtech Group Says FY Profit Attributable RMB631.8 Mln, Up 670.7%
HK-listed PW Medtech hits over 3-1/2-year high on sale of stake in CBPO
Brief: Pw Medtech Enters 3 Share Purchase Agreements
Brief: Pw Medtech Group Says HY Profit Attributable RMB 141.2 Mln
Brief: PW Medtech Group Sees Decrease In HY Revenue From Group's Infusion Set Business In Range Of 35% To 45%
Brief: PW Medtech Group Posts FY Profit Attributable From Cont Ops Of RMB82.0 Mln